A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 186 participants.
Also called NCT01665352
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 186 participants
- Sponsor
- Registry
-
NCT01665352
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01665352. Randomized; double masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2013-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- TTP054
- Intervention (Drug)
- Placebo
- Lead sponsor
- vTv Therapeutics
Record details
- Record id
cardio:ct-nct01665352- Content hash
97752485609795462e47e20355e3dddf6556cbc75bdefa38f4730f9ba3ace46c